These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1868762)

  • 1. [Effect of chronic antiplatelet treatment on platelet activating factor-induced platelet activity in stroke].
    Han E; Joseph R; Grunfeld S; Welch KM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):21-3, 61. PubMed ID: 1868762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
    Joseph R; Welch KM; D'Andrea G
    Stroke; 1989 May; 20(5):609-11. PubMed ID: 2718200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
    Viero P; Cortelazzo S; Barbui T; de Gaetano G
    Haemostasis; 1986; 16(1):27-33. PubMed ID: 3699584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stroke, platelet activating factor and receptor antagonists].
    Wang ZG; Wang DQ; Jiao Y; Tian X; Sun MY
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4750-4755. PubMed ID: 29493142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
    Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
    J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).
    Cargill DI; Cohen DS; Van Valen RG; Klimek JJ; Levin RP
    Thromb Haemost; 1983 Jun; 49(3):204-7. PubMed ID: 6879508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects.
    Hong Y; Gengo FM; Rainka MM; Bates VE; Mager DE
    Clin Pharmacokinet; 2008; 47(2):129-37. PubMed ID: 18193919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways.
    Lauri D; Cerletti C; de Gaetano G
    J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke therapy: status of anti-platelet aggregation drugs.
    Yatsu FM
    Neurology; 1977 Jun; 27(6):503-4. PubMed ID: 325429
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
    Gao BT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):148-51, 191. PubMed ID: 2591268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine release from rabbit platelets by platelet-activating factor (PAF).
    Nakahodo K; Saitoh S; Nakamura M; Kosugi T
    Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.